(Note: Vital Human Capital, Inc., a SPAC or blank-check company whose sponsor is affiliated with ShiftPixy, withdrew its IPO in an SEC filing dated March 18, 2022. This SPAC filed its S-1 on April 29, 2021, with plans to raise $250 million. The SPAC IPO’s size was cut to $150 million in an S-1/A filing […]

(Note: TechStackery, Inc., withdrew its SPAC (blank-check) IPO in an SEC filing dated March 18, 2022. The company filed its S-1 in late April 2021, with plans for a $250 million IPO. The size was cut to $150 million in an S-1/A filing dated Aug. 24, 2022.) We intend to focus on private companies distressed […]

SOS Hydration, Inc. was founded by a veteran, a physician and a former professional track athlete, who were driven by their desire for a hydration product that could absorb quickly and had less sugar available products. SOS is an electrolyte replacement drink in the hydration drink category that provides products with less sugar than traditional […]

As a holding company with no material operations of our own, our operations are conducted through our subsidiaries in the People’s Republic of China (the “PRC”), Taiwan, Hong Kong and Samoa, with our headquarters in Taiwan, and such structure involves unique risks to investors, as the Chinese government may exercise significant oversight and discretion over […]

We are a leading export-oriented manufacturer and seller of toner cartridges compatible with a wide range of laser printers. We are based in China. Our products are sold in 45 countries. Sales in the U.S. and Europe represent the majority of our revenue. (Incorporated in the Cayman Islands) Our mission is to deliver high-quality and cost-effective printing solutions […]

(New Beginnings Acquisition Corp. III withdrew its IPO plans in an SEC filing dated March 18, 2022; the SPAC or blank-check company filed to go public on March 9, 2021.) We intend to initially focus on companies in the travel, hospitality, leisure, financial technology (FinTech), insurance technology and property technology (PropTech) sectors outside of the […]

We are a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Our lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH), for […]

We intend to focus our search for a target operating in an alternative energy industry, including clean energy and storage, smart grid/efficiency, environmental services and recycling, mobility, water and wastewater management, advanced materials and technology enabled services. (Incorporated in the Cayman Islands)  (Note: Spring Valley Acquisition Corp. II priced its SPAC IPO on Oct. 12, […]

(Note: Virax Biolabs Group Limited priced its IPO on July 20, 2022, in sync with the terms in its prospectus: 1.35 million shares at $5 each to raise $6.75 million.) We are a holding company incorporated as an exempted company under the laws of the Cayman Islands. As a holding company with no material operations […]

We intend to focus on businesses in clean energy sectors that have their primary operations located in the Asia-Pacific region. We will focus on businesses with enterprise values between $200 million and $800 million. We believe that we will add value to these businesses primarily by providing them with access to the U.S. capital markets. (Incorporated in the British […]